Endovenous laser therapy (ELT)closes and shrinks the varicose vein and causes scar tissue within the vesselin order to seals off the vein and promote blood flow through other nearbyveins.
The global EndovenousLaser Therapy Market is estimated to account for US$ 329.3 Mn in terms ofvalue and is estimated to reach US$ 591.1 Mn by the end of 2027.
Global Endovenous Laser TherapyMarket: Drivers
Increasing adoption of endovenouslaser ablation therapy is expected to propel growth of the global endovenouslaser therapy market over the forecast period. Endovenous laser ablationtherapy is a minimally invasive procedure that makes use of catheters, lasers,and ultrasound to treatment of varicose veins. The procedure requires less time(around an hour) and one small incision. Moreover, the recovery time of patientis also low. These advantages boost adoption of endovenous laser ablationtherapy, thereby propelling growth of the market.
Global Endovenous Laser TherapyMarket: Opportunities
Increasing prevalence of obesityis expected to offer lucrative growth opportunities for players in the globalendovenous laser therapy market as the condition is a high risk factor forvaricose veins. For instance, according to MedAlertHelp.org, over 1.9 billionadults were reported as overweight worldwide.
Global Endovenous Laser TherapyMarket: Restraints
Unfavourable reimbursementscenario in some economies is expected to hinder growth of the globalendovenous laser therapy market. For instance, in France, only radiofrequencyis reimbursed and not endovenous laser ablation therapy.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/3377
Key Takeaways:
The diode lasers segment in theglobal endovenous laser therapy market was valued at US$ 201.3 Mn in 2018 andis expected to reach US$ 394.9 Mn by 2027 at a CAGR of 7.6% during the forecastperiod. Diode lasers are used in several endovenous laser systems which issupporting growth of the segment. For instance, VenaCure EVLT 1470 Promanufactured by AngioDynamics uses high-performing diode laser
The ambulatory surgical centerssegment held dominant position in the global endovenous laser therapy market in2018, accounting for 35.7% share in terms of value, followed by hospitals andspecialized clinics, respectively.
Ambulatory surgical centersperform outdoor patient surgeries for which overnight patient admission is notnecessary. These type of centers save time as well as costs which is expectedto support growth of the segment over the forecast period.
The North America region helddominant position in the global endovenous laser therapy market in 2018,accounting for 42.4% share in terms of value, followed by Europe and AsiaPacific, respectively.
Factors such as presence of keyplayers in the region, and product launches is expected to support growth ofthe region over the forecast period. For instance, AngioDynamics, a provider ofendovenous laser therapy products is based in the U.S.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/endovenous-laser-therapy-market-3377
Market Trends
In countries such as the U.S.,endovenous laser therapy for varicose veins is majorly performed in clinicsrather than hospitals in order avoid long-time waiting in big hospitalsettings, which is why physicians are rapidly adopting laser therapy systems.
In Denmark, prior authorizationfor using endovenous laser ablation is not required and all patients arecovered through state health insurance.
Global Endovenous Laser TherapyMarket: Competitive Landscape
Major players operating in theglobal endovenous laser therapy market include, AngioDynamics, Inc., CandelaCorporation, Dornier MedTech GmbH, Alma Lasers Ltd., Alna-Medicalsystem GmbH,LSO Medical, Wontech Co., Ltd., Intros Medical Laser GmbH, and Energist Ltd.
Global Endovenous Laser TherapyMarket: Key Developments
October 2019: AngioDynamics, Inc.acquired Eximo Medical, Ltd., an early commercial stage, medical devicecompany, and its proprietary 355nm wavelength laser-technology platform
May 2019: Candela Corporationpartnered with The Vascular Birthmarks Foundation and E.V.A. Clinic to providepro-bono laser treatments
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/3377
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S. Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
